Orchid Pharma

Orchid Pharma Ltd Balance Sheet

NSEBSE

₹728.8

(0.06%)

Jun 10, 2025|01:14:56 PM

Invest wise with Expert advice

QUICKLINKS FOR Orchid Pharma Ltd

FINANCIALS

Profit & Loss Balance Sheet Cash Flow Ratios Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Equity Capital	119.28	109.38	109.38	109.38
Preference Capital	0	0	0	0
Reserves	1,099.04	622.59	568.58	571.96
Net Worth	1,218.32	731.97	677.96	681.34
Minority Interest
Debt	134.96	331.34	267.95	452.74
Deferred Tax Liability Net	110.81	89.33	86.06	152.57
Total Liabilities	1,464.09	1,152.64	1,031.97	1,286.65
Fixed Assets	640.89	619.15	593.44	677.82
Intangible Assets
Investments	69.4	50.12	49.01	15.43
Deferred Tax Asset Net	110.81	86.11	82.83	149.34
Networking Capital	385.77	374.93	302.49	425.1
Inventories	264.23	228.74	172.66	150.57
Inventory Days			113.14	121.94
Sundry Debtors	189.37	211.91	160.23	131.96
Debtor Days			105	106.86
Other Current Assets	131.09	91.01	114.66	229.73
Sundry Creditors	-180.3	-137.43	-121.25	-71.27
Creditor Days			79.45	57.71
Other Current Liabilities	-18.62	-19.3	-23.81	-15.89
Cash	257.23	22.34	4.21	18.97
Total Assets	1,464.1	1,152.65	1,031.98	1,286.66

Orchid Pharma : related Articles

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal

20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.